Imaging in acute percutaneous mechanical circulatory support in adults: a clinical consensus statement of the Association for Acute CardioVascular Care (ACVC) of the ESC, the European Association of Cardiovascular Imaging (EACVI) of the ESC and the European branch of the Extracorporeal Life Support Organization (EuroELSO)
- PMID: 39180134
- DOI: 10.1093/ehjci/jeae219
Imaging in acute percutaneous mechanical circulatory support in adults: a clinical consensus statement of the Association for Acute CardioVascular Care (ACVC) of the ESC, the European Association of Cardiovascular Imaging (EACVI) of the ESC and the European branch of the Extracorporeal Life Support Organization (EuroELSO)
Abstract
The use of temporary mechanical circulatory support (tMCS) in cardiogenic shock patients has increased during the last decades with most management strategies relying on observational studies and expert opinion, including hemodynamic monitoring, device selection, and timing of support institution/duration. In this context, imaging has a pivotal role throughout the patient pathway, from identification to initiation, monitoring, and weaning. This manuscript summarizes the consensus of an expert panel from the European Society of Cardiology Association for Acute CardioVascular Care, the European Association of CardioVascular Imaging, and the European Extracorporeal Life Support Organization, providing the rationale for and practical guidance of imaging to tMCS based on existing evidence and consensus on best current practice.
Keywords: clinical; imaging; management; mechanical circulatory support; ultrasound.
© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Conflict of interest statement
Conflict of interest: J.E.M.: Institutional research grant from the NOVO Nordic foundation, Abiomed and Danish Heart Foundation, speakers honorarium Abbott, Boehringer Ingelheim and Abiomed. F.G.: Research grant from AOP Orphan, and speaker honorarium from Abbott, Edwards, Orion, Orphan. C.H.: Research grant from Lundbeck Foundation, Novo Nordisk Foundation, and the Danish Heart Foundation, speakers honorarium from Abiomed. S.L.: Research grant from VLAIO, speaker honorarium from Menarini and proctoring honorarium from Abbott. D.W.D.: Research consultancy to Maquet Critical Care AB, Solna, Sweden and HBOX GmbH, Aachen, Germany, and research cooperation with Sonion BV, Hoofddorp, the Netherlands. All financial compensation for these activities is paid to the University of Twente, Enschede, the Netherlands, no personal fees received. J.O.B.: Speaker honorarium and proctoring honorarium from Abbott. All other authors have nothing to disclose.
